Infectious Diseases Practice Guidelines

SOURCE: Infectious Diseases Society of America (IDSA)

Guidelines from the Infectious Diseases Society of America
SOURCE: Clinical Infectious Diseases 1997;25:551-73 (348 kb PDF)

Guidelines from the Infectious Diseases Society of America
SOURCE: Clinical Infectious Diseases 1997;25:787-801 (238 kb PDF)

Guidelines from the Infectious Diseases Society of America
SOURCE: Clinical Infectious Diseases 1997;25:584-99 (265 kb PDF)

Infectious Diseases Society of America Quality Standards for Infectious Diseases
SOURCE: Clinical Infectious Diseases 1994;18:422-7 (68 kb PDF)

SOURCE: American College of Physicians-American Society of Internal Medicine (ACP-ASIM)

To provide physicians and other transfusion medicine professionals with a current consensus on infectious disease testing for blood transfusions.A non-Federal, nonadvocate, 12-member consensus panel representing the fields of hematology, infectious disease, transfusion medicine, epidemiology, and biostatistics and a public representative. In addition, 23 experts in hematology, cardiology, transfusion medicine, infectious disease, and epidemiology presented data to the consensus panel and a conference audience of 450.
SOURCE: National Institutes of Health Consensus Development Conference Statement, 1995

SOURCE: Infectious Diseases Society of America (IDSA)

Position Statement From the Infectious Diseases Society of America
SOURCE: Clinical Infectious Diseases 1998;26:1042-59 (264 kb PDF)

SOURCE: Infectious Diseases Society of America (IDSA)

This primer is intended to help physicians by providing practical and concise information on the diagnosis, treatment, and reporting of foodborne illnesses. It was developed collaboratively by the AMA, CDC, the FDA's Center for Food Safety and Applied Nutrition, and the USDA's Food Safety and Inspection Service.
SOURCE: MMWR. January 26, 2001 / 50(RR02);1-69

Peptic ulcer disease is a chronic inflammatory condition of the stomach and duodenum that affects as many as 10 percent of people in the United States at some time in their lives.
SOURCE: National Institutes of Health Consensus Development Conference Statement, 1994

SOURCE: Infectious Diseases Society of America (IDSA)

To achieve a sustained reduction in hepatitis A rates, the Advisory Committee on Immunization Practices (ACIP) has published these revisions to the 1996 recommendations.
SOURCE: MMWR. October 01, 1999 / 48(RR12);1-37

The recommendations in this report provide broader guidelines for a) preventing transmission of HCV; b) identifying, counseling, and testing persons at risk for HCV infection; and c) providing appropriate medical evaluation and management of HCV-infected persons.
SOURCE: Centers for Disease Control, 1998

The hepatitis C virus (HCV) is one of six viruses (A, B, C, D, E, and G) that together account for the majority of cases of viral hepatitis.
SOURCE: National Institutes Of Health Consensus Development Conference Statement, 1997

This report presents the recommended childhood immunization schedule for 2000, including a table, and explains the changes that have occurred since January 1999.
SOURCE: Advisory Committee on Immunization Practices, 2000 (MMWR 49(02);35-38,47)

Combination vaccines represent one solution to the problem of increased numbers of injections during single clinic visits. This statement provides general guidance on the use of combination vaccines and related issues and questions.
SOURCE: Advisory Committee on Immunization Practices, 1999 (MMWR 48(RR05);1-15)

These recommendations can assist hospital administrators, infection control practitioners, employee health physicians, and HCWs in optimizing infection prevention and control programs.
SOURCE: Advisory Committee on Immunization Practices, 1997 (MMWR 46(RR-18);1-42)

Recommendations include immunization for influenza, hepatitis A and B, and tetanus.
SOURCE: National Coalition for Adult Immunization, 1999

Recommendations include immunization for influenza, hepatitis A and B, measles/mumps/rubella, and tetanus/diphtheria.
SOURCE: National Coalition for Adult Immunization, 1999

SOURCE: MMWR 48(RR14):1-9, 1999. Centers for Disease Control

These recommendations update information concerning the vaccine and antiviral agents available for controlling influenza during the 2000-2001 influenza season.
SOURCE: Advisory Committee on Immunization Practices, 2000

This report provides recommendations for use of a newly developed recombinant outer-surface protein A (rOspA) Lyme disease vaccine (LYMErix,TM SmithKline Beecham Pharmaceuticals) for persons aged 15-70 years in the United States. The purpose of these recommendations is to provide health-care providers, public health authorities, and the public with guidance regarding the risk for acquiring Lyme disease and the role of vaccination as an adjunct to preventing Lyme disease.
SOURCE: Advisory Committee on Immunization Practices, 1999

Lyme disease is a complex, multisystem disease caused by the spirochete Borrelia burgdorferi. It affects people of all ages and is the the most common tick-borne disease in North America. These guidelines review the immunological tests available and their benefits and drawbacks.
SOURCE: Annals of Internal Medicine 15 December 1997. 127:1106-1108.

Recent successes in interrupting indigenous transmission of measles virus in the Americas and in the United Kingdom prompted the World Health Organization (WHO), Pan American Health Organization (PAHO), and CDC to convene a meeting in July, 1996 to consider the feasibility of global measles eradication.
SOURCE: World Health Organization, the Pan American Health Organization, and Centers for Disease Control, 1996

Infectious Diseases Society of America Quality Standards for Infectious Diseases
SOURCE: Clinical Infectious Diseases 1994;18:431-6 (61 kb PDF)

This report describes 10 steps for evaluation and management of suspected serogroup C meningococcal disease outbreaks. The principles described also apply to suspected outbreaks caused by meningococcal serogroups A, Y, and W-135.
SOURCE: Advisory Committee on Immunization Practices, 1997

This report provides additional information regarding meningococcal vaccines and the addition of ciprofloxacin and ceftriaxone as acceptable alternatives to rifampin for chemoprophylaxis in selected populations.
SOURCE: Advisory Committee on Immunization Practices, 1997

SOURCE: NATIONAL GUIDELINE CLEARINGHOUSE

SOURCE: American College of Physicians-American Society of Internal Medicine (ACP-ASIM)

CDC's ACIP recommends that the new 7-valent pneumococcal polysaccharide-protein conjugate vaccine be used for all children aged 2--23 months and for children aged 24--59 months who are at increased risk for pneumococcal disease (e.g., children with sickle cell disease, HIV infection, and other immunocompromising or chronic medical conditions).
SOURCE: Advisory Committee on Immunization Practices, 2000

This report contains updated information regarding a) antimicrobial resistance among pneumococci, b) vaccine effectiveness and cost-effectiveness, c) indications for vaccination, d) guidelines for revaccination, e) strategies for improving delivery of vaccine, and f) development of pneumococcal conjugate vaccine.
SOURCE: Advisory Committee on Immunization Practices, 1997

As of January 1, 2000, ACIP recommends exclusive use of inactivated poliovirus vaccine (IPV) for routine childhood polio vaccination in the United States. All children should receive four doses of IPV at ages 2, 4, and 6--18 months and 4--6 years.
SOURCE: Advisory Committee on Immunization Practices, 2000

Position Statement From the Infectious Diseases Society of America
SOURCE: Clinical Infectious Diseases 1998;26:1037-41 (122 kb PDF)

Position Statement From the Infectious Diseases Society of America
SOURCE: Clinical Infectious Diseases 1997;25:802 (61 kb PDF)

Infectious Diseases Society of America Quality Standards for Infectious Diseases
SOURCE: Clinical Infectious Diseases 1994;18:421 (21 kb PDF)

Infectious Diseases Society of America Quality Standards for Infectious Diseases
SOURCE: Clinical Infectious Diseases 1994;18:428-30 (42 kb PDF)

Infectious Diseases Society of America Quality Standards for Infectious Diseases
SOURCE: Clinical Infectious Diseases 1994;18:431-6 (61 kb PDF)

This report includes new information about a human rabies vaccine approved for U.S. use in 1997, recommendations regarding exposure to bats, recommendations regarding an observation period for domestic ferrets, and changes in the local administration of rabies immune globulin.
SOURCE: Advisory Committee on Immunization Practices, 1999

Position Statement From the Infectious Diseases Society of America
SOURCE: Clinical Infectious Diseases 1998;26:811-38 (419 kb PDF)

This document updates and replaces CDC's previously published 'Guideline for Prevention of Nosocomial Pneumonia.'
SOURCE: Centers for Disease Control and Hospital Infection Control Practices Advisory Committee, 1997

This guideline provides recommendations for the management of community-acquired pneumonia and the surveillance of drug-resistant Streptococcus pneumoniae.
SOURCE: Arch Intern Med. 2000;160:1399-1408

An update of a previously published National Guidelines Clearinghouse guideline summary.
SOURCE: Infectious Diseases Society of America (IDSA)

SOURCE: American College of Physicians-American Society of Internal Medicine (ACP-ASIM)

SOURCE: American College of Physicians-American Society of Internal Medicine (ACP-ASIM)

SOURCE: MMWR 47(RR-1);1-118, 1998

Guidelines from the Infectious Diseases Society of America
SOURCE: Clinical Infectious Diseases 1997;25:574-83 (214 kb PDF)

Group B streptococcus is a leading cause of serious neonatal infection. Most neonatal GBS infections can be prevented through the use of intrapartum antimicrobial prophylaxis in women who are at increased risk for transmitting the infection to their newborns.
SOURCE: National Center for Infectious Diseases, 1996

Toxoplasma infection can be prevented in large part by a) cooking meat to a safe temperature (i.e., one sufficient to kill Toxoplasma); b) peeling or thoroughly washing fruits and vegetables before eating; c) cleaning cooking surfaces and utensils after they have contacted raw meat, poultry, seafood, or unwashed fruits or vegetables; d) pregnant women avoiding changing cat litter or, if no one else is available to change the cat litter, using gloves, then washing hands thoroughly; and e) not feeding raw or undercooked meat to cats and keeping cats inside to prevent acquisition of Toxoplasma by eating infected prey.
SOURCE: National Center for Infectious Diseases, 2000

SOURCE: June 09, 2000 / 49(RR06);1-54

Existing TB-control efforts must be sustained and enhanced, and new and improved diagnostic, treatment, and prevention methods, including a new vaccine, must be developed and applied. Support for these efforts should be broad-based and include the establishment of new partnerships.
SOURCE: Advisory Council for the Elimination of Tuberculosis, 1999

As the percentage of reported TB cases among foreign-born persons continues to increase, the elimination of TB in the United States will depend increasingly on the elimination of TB among foreign-born persons.
SOURCE: CDC's Division of TB Elimination and Division of Quarantine, 1998

The recommendations contained in this report update and expand previously published recommendations for preventing and controlling tuberculosis (TB) in correctional facilities (MMWR 1989;38:313-20, 325).
SOURCE: Advisory Council for the Elimination of Tuberculosis, 1995

SOURCE: Infectious Diseases Society of America (IDSA)

The purpose of this guideline is to provide assistance to clinicians in the diagnosis and treatment of two specific types of urinary tract infections (UTIs): uncomplicated, acute, symptomatic bacterial cystitis and acute pyelonephritis in women.
SOURCE: IDSA Practice Guidelines Committee, 1999 (Clin Infect Dis 1999;29:745-58)

In February 1999, the Advisory Committee on Immunization Practices (ACIP) expanded recommendations for varicella (chickenpox) vaccine to promote wider use of the vaccine for susceptible children and adults. The updated recommendations include establishing child care and school entry requirements, use of the vaccine following exposure and for outbreak control, use of the vaccine for some children infected with the human immunodeficiency virus (HIV), and vaccination of adults and adolescents at high risk for exposure.
SOURCE: Advisory Committee on Immunization Practices, 1999